US Patent Issued to ANTECIP BIOVENTURES II on April 14 for "Treatment of poor metabolizers of dextromethorphan with a combination of bupropion and dextromethorphan" (New York Inventor)

ALEXANDRIA, Va., April 15 -- United States Patent no. 12,599,576, issued on April 14, was assigned to ANTECIP BIOVENTURES II LLC (New York).

"Treatment of poor metabolizers of dextromethorphan with a combination of bupropion and dextromethorphan" was invented by Herriot Tabuteau (New York).

According to the abstract* released by the U.S. Patent & Trademark Office: "Disclosed herein is a method of safely treating a nervous system condition with a combination of dextromethorphan and bupropion. This method is intended for patients having a neurological condition or a psychiatric condition, such as major depressive disorder, and a CYP2D6 poor metabolizer genotype or a CYP2D6 poor metabolizer phenotype."

The patent was filed on July 9, 2025, ...